382 related articles for article (PubMed ID: 16232221)
1. The effects of atorvastatin on gluten-induced intestinal T cell responses in coeliac disease.
Ráki M; Molberg O; Tollefsen S; Lundin KE; Sollid LM
Clin Exp Immunol; 2005 Nov; 142(2):333-40. PubMed ID: 16232221
[TBL] [Abstract][Full Text] [Related]
2. A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells.
Ráki M; Tollefsen S; Molberg Ø; Lundin KE; Sollid LM; Jahnsen FL
Gastroenterology; 2006 Aug; 131(2):428-38. PubMed ID: 16890596
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease.
Di Sabatino A; Pickard KM; Gordon JN; Salvati V; Mazzarella G; Beattie RM; Vossenkaemper A; Rovedatti L; Leakey NA; Croft NM; Troncone R; Corazza GR; Stagg AJ; Monteleone G; MacDonald TT
Gastroenterology; 2007 Oct; 133(4):1175-87. PubMed ID: 17919493
[TBL] [Abstract][Full Text] [Related]
4. Gluten-free diet induces regression of T-cell activation in the rectal mucosa of patients with celiac disease.
Cellier C; Cervoni JP; Patey N; Leborgne M; Marteau P; Landi B; Cerf-Bensussan N; Barbier JP; Brousse N
Am J Gastroenterol; 1998 Sep; 93(9):1527-30. PubMed ID: 9732937
[TBL] [Abstract][Full Text] [Related]
5. Surface expression of transglutaminase 2 by dendritic cells and its potential role for uptake and presentation of gluten peptides to T cells.
Ráki M; Schjetne KW; Stamnaes J; Molberg Ø; Jahnsen FL; Issekutz TB; Bogen B; Sollid LM
Scand J Immunol; 2007 Mar; 65(3):213-20. PubMed ID: 17309775
[TBL] [Abstract][Full Text] [Related]
6. Celiac disease: from pathogenesis to novel therapies.
Schuppan D; Junker Y; Barisani D
Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis.
Phoon RK; Kitching AR; Jones LK; Holdsworth SR
Nephrology (Carlton); 2009 Oct; 14(7):650-7. PubMed ID: 19796023
[TBL] [Abstract][Full Text] [Related]
8. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls.
Molberg O; Kett K; Scott H; Thorsby E; Sollid LM; Lundin KE
Scand J Immunol; 1997 Jul; 46(1):103-8. PubMed ID: 9246215
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of statins on relevant functions of human monocyte-derived dendritic cells.
Yilmaz A; Reiss C; Weng A; Cicha I; Stumpf C; Steinkasserer A; Daniel WG; Garlichs CD
J Leukoc Biol; 2006 Mar; 79(3):529-38. PubMed ID: 16387846
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T cells are preferentially activated in the duodenal epithelium from patients with florid coeliac disease.
Buri C; Burri P; Bähler P; Straumann A; Müller-Schenker B; Birrer S; Mueller C
J Pathol; 2005 Jun; 206(2):178-85. PubMed ID: 15880760
[TBL] [Abstract][Full Text] [Related]
11. Gluten intolerance (coeliac disease).
Ferguson A; Ziegler K; Strobel S
Ann Allergy; 1984 Dec; 53(6 Pt 2):637-42. PubMed ID: 6391293
[TBL] [Abstract][Full Text] [Related]
12. Celiac disease pathogenesis: the proinflammatory cytokine network.
Garrote JA; Gómez-González E; Bernardo D; Arranz E; Chirdo F
J Pediatr Gastroenterol Nutr; 2008 Aug; 47 Suppl 1():S27-32. PubMed ID: 18667914
[TBL] [Abstract][Full Text] [Related]
13. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.
Blanco-Colio LM; Muñoz-García B; Martín-Ventura JL; Lorz C; Díaz C; Hernández G; Egido J
Circulation; 2003 Sep; 108(12):1506-13. PubMed ID: 12952848
[TBL] [Abstract][Full Text] [Related]
14. IFNalpha treatment generates antigen-presenting cells insensitive to atorvastatin inhibition of MHC-II expression.
López P; Gutiérrez C; Suárez A
Clin Immunol; 2008 Nov; 129(2):350-9. PubMed ID: 18757244
[TBL] [Abstract][Full Text] [Related]
15. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease.
Bodd M; Kim CY; Lundin KE; Sollid LM
Gastroenterology; 2012 Mar; 142(3):552-61. PubMed ID: 22108197
[TBL] [Abstract][Full Text] [Related]
16. Future therapeutic options for celiac disease.
Sollid LM; Khosla C
Nat Clin Pract Gastroenterol Hepatol; 2005 Mar; 2(3):140-7. PubMed ID: 16265155
[TBL] [Abstract][Full Text] [Related]
17. The distribution of gluten-sensitive lymphocytes in coeliac patients--is it related to dietary gluten?
Howdle PD; Simpson FG; Losowsky MS
Clin Exp Immunol; 1986 Nov; 66(2):393-8. PubMed ID: 3815897
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of mucosal addressin cell adhesion molecule 1 in the duodenum of patients with active celiac disease is associated with depletion of integrin alpha4beta7-positive T cells in blood.
Di Sabatino A; Rovedatti L; Rosado MM; Carsetti R; Corazza GR; MacDonald TT
Hum Pathol; 2009 May; 40(5):699-704. PubMed ID: 19157500
[TBL] [Abstract][Full Text] [Related]
19. Cell-mediated immunity to gluten fraction III in adult coeliac disease.
Holmes GK; Asquith P; Cooke WT
Clin Exp Immunol; 1976 May; 24(2):259-65. PubMed ID: 1277578
[TBL] [Abstract][Full Text] [Related]
20. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses.
Vader W; Stepniak D; Kooy Y; Mearin L; Thompson A; van Rood JJ; Spaenij L; Koning F
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12390-5. PubMed ID: 14530392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
